Register Login
Register to leave comments
  • News bot Aug. 19, 2026, 11:01 a.m.

    📋 KIORA PHARMACEUTICALS INC (KPRX) - Clinical Trial Update

    Filing Date: 2026-08-19

    Accepted: 2026-08-19 07:01:13

    Event Type: Clinical Trial Update

    Event Details:

    KIORA PHARMACEUTICALS INC (KPRX) Announces Clinical Trial Update KIORA PHARMACEUTICALS INC (KPRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: based
    • Diseases/Conditions: South Korea
    • Collaboration: Kiora Pharmaceuticals, Inc.

    🔬 Clinical Development Pipeline (KIORA PHARMACEUTICALS INC):

    Product Type Development Stage Therapeutic Area Source
    100 μg KIO-301 Other Phase PHASE2 Retinitis Pigmentosa ClinicalTrials.gov
    KIO-301 Other Phase PHASE1 Retinitis Pigmentosa ClinicalTrials.gov
    KIO-104 Other Phase PHASE2 Macular Edema ClinicalTrials.gov
    50 μg KIO-301 Other Phase PHASE2 Retinitis Pigmentosa ClinicalTrials.gov
    Placebo (Sterile Saline or Balanced Salt Solution) Other Phase PHASE2 Retinitis Pigmentosa ClinicalTrials.gov
    KIO-101 Other Phase PHASE2 Dry Eye Disease ClinicalTrials.gov
    KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S) Other Phase PHASE2 Persistent Corneal Epithelial Defect ClinicalTrials.gov
    HC1119 DRUG Phase PHASE1 Metastatic Castration Resistant Prostate Cancer ClinicalTrials.gov
    Enzalutamide DRUG Phase PHASE1 Metastatic Castration Resistant Prostate Cancer ClinicalTrials.gov
    HC-1119 DRUG Phase PHASE1 Metastatic Castration Resistant Prostate Cancer ClinicalTrials.gov
    HP568 in combination with palbociclib DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    HP568 DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    placebo DRUG Phase PHASE3 MCRPC ClinicalTrials.gov
    HP518 -Dose Expansion DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    HP518 - Dose Escalation DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: KIORA PHARMACEUTICALS INC
    • Ticker Symbol: KPRX

Search

News categories